DELIFAB RD3 30CPR
-12%
(le immagini sono puramente indicative)
DELIFAB RD3 30CPR
€ 22,37 € 25,50
- Disponibilità: Disponibile
- Brand: ELIFAB Srl
- Codice prodotto: 931960811
- Punti fedeltà: 44
-
ATTENZIONE:
In caso di esaurimento scorte, l'ordine potrebbe subire un ritardo sui normali tempi di evasione.
DELIFAB
RD3
Non superare la dose giornaliera raccomandata.
Tenere fuori dalla portata dei bambini al di sotto dei 3 anni di età.
Gli integratori non vanno intesi come sostituti di una dieta variata.
Bibliografia
- 1. Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Wood LG, Wark PA, Garg ML. Antioxid Redox Signal. 2010 Nov 15;13(10):1535-48. Rewiew.
- 2. Oxidative stress and redox regulation of lung infiammation in COPD. Rahman I, Adcock IM. Eur Respir J. 2006 Jul; 28(1):219-42.
- 3. Antioxidant therapeutic advances in COPD. Rahman I. Ther Adv Respir Dis. 2008 Dec;2(6):351-74.
- 4. Resveratrol inhibits Respiratory Syncytial Virus-Induced IL-6 Production, Decreases Viral Replication, and Downregulates TRIF Expression in Airway Epithelial Cells. Xie XH, Inflammation. 2012 Mar 7.
- 5. Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling. Narumoto O, Exp Mol Pathol. 2012 Apr 19;93(1):18-25. [Epub ahead of print].
- 6. Potential Therapeutic Effects of Curcumin, the Anti-infiammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases - Bharat B. Aggarwal,Int J Biochem Cell Biol 2009.
- 7. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Marwick JA, Expert Opin Ther Targets. 2007 Jum; 11(6):745-55.
- 8. Quercetin inhibits rhinovirus replication in vitro and in vivo. Ganesan S, Antiviral Res. 2012 Jun;94(3):258-71. Epub 2012 Mar 23.
- 9. Immunosuppressive effect of quercetin on dendritic cell actication and function. Huang RY, J Immunol. 2010 Jun 15;184(12):6815-21.
- 10. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Bozzetto S, Allergy. 2012.
- 11. Vitamin D Deficiency. Michael F. Holick, N Eng J med 2007.
- 12. Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma. E. Rand Sutherland, Am J Respir Crit Care Med Vol 181. pp 699-704, 2010.
- 13. Decreased serum vitamin D levels in children with asthma are associated with increased coticosteroid use. Searing DA, J Allergy Clin Immunol. 2010 May;127(5):1294-6.
- 14. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection Majak P, J Allergy Clin Immunol. 2011 May;127(5):1294-6.
- 15. Modulatory effects of selenium and zinc on the immune system. Ferencik M, Folia Microbiol 2003;48(3):417-26.
- 16. Zinc: role in immunity, oxidative stress and chronic infiammation. Prasad AS. Curr Opin Clin Nutr Metab Care. 2009;12:646-52.
RD3
Descrizione del parafarmaco Delifab Rd3 30cpr
Integratore alimentare a base di quercitina, curcumina, resveratrolo, zinco e vitamina D.Ingredienti
per dose giornaliera (2 compresse) Resveratrolo20 mg Curcumina200 mg Quercitina200 mg Vitamina D3 100000 UI/g400 UI Zinco10 mgQuali sono le modalità d'uso di Delifab Rd3 30cpr ?
Si consiglia l'assunzione di 2 compresse al giorno.Avvertenze
In caso di alterazioni della funzione epatica, biliare o di calcolosi delle vie biliari, l'uso del prodotto è sconsigliato. Se si stanno assumendo farmaci, è opportuno sentire il parere del medico. Per donne in gravidanza o in allattamento e bambini si raccomanda di sentire il parere del medico.Non superare la dose giornaliera raccomandata.
Tenere fuori dalla portata dei bambini al di sotto dei 3 anni di età.
Gli integratori non vanno intesi come sostituti di una dieta variata.
Formato
30 compresse.Bibliografia
- 1. Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Wood LG, Wark PA, Garg ML. Antioxid Redox Signal. 2010 Nov 15;13(10):1535-48. Rewiew.
- 2. Oxidative stress and redox regulation of lung infiammation in COPD. Rahman I, Adcock IM. Eur Respir J. 2006 Jul; 28(1):219-42.
- 3. Antioxidant therapeutic advances in COPD. Rahman I. Ther Adv Respir Dis. 2008 Dec;2(6):351-74.
- 4. Resveratrol inhibits Respiratory Syncytial Virus-Induced IL-6 Production, Decreases Viral Replication, and Downregulates TRIF Expression in Airway Epithelial Cells. Xie XH, Inflammation. 2012 Mar 7.
- 5. Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling. Narumoto O, Exp Mol Pathol. 2012 Apr 19;93(1):18-25. [Epub ahead of print].
- 6. Potential Therapeutic Effects of Curcumin, the Anti-infiammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases - Bharat B. Aggarwal,Int J Biochem Cell Biol 2009.
- 7. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Marwick JA, Expert Opin Ther Targets. 2007 Jum; 11(6):745-55.
- 8. Quercetin inhibits rhinovirus replication in vitro and in vivo. Ganesan S, Antiviral Res. 2012 Jun;94(3):258-71. Epub 2012 Mar 23.
- 9. Immunosuppressive effect of quercetin on dendritic cell actication and function. Huang RY, J Immunol. 2010 Jun 15;184(12):6815-21.
- 10. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Bozzetto S, Allergy. 2012.
- 11. Vitamin D Deficiency. Michael F. Holick, N Eng J med 2007.
- 12. Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma. E. Rand Sutherland, Am J Respir Crit Care Med Vol 181. pp 699-704, 2010.
- 13. Decreased serum vitamin D levels in children with asthma are associated with increased coticosteroid use. Searing DA, J Allergy Clin Immunol. 2010 May;127(5):1294-6.
- 14. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection Majak P, J Allergy Clin Immunol. 2011 May;127(5):1294-6.
- 15. Modulatory effects of selenium and zinc on the immune system. Ferencik M, Folia Microbiol 2003;48(3):417-26.
- 16. Zinc: role in immunity, oxidative stress and chronic infiammation. Prasad AS. Curr Opin Clin Nutr Metab Care. 2009;12:646-52.